Long-Term Partnership with Salix in the Therapeutic Area of Digestive Health

Long-Term Partnership with Salix in the Therapeutic Area of Digestive Health

Linda Masello, Salix CEO, and Martina Perharič, Medis CEO, signing agreement at Medis HQ in Ljubljana, Slovenia

Medis has signed a long-term production and distribution agreement with Salix, one of the leading global manufacturers of food supplements and medical devices. Under the agreement, Salix and Medis are exclusive partners for the production and marketing of a new and innovative digestive health product in 11 different markets across the CEE region. 

Medis Consumer Health business unit will be responsible for registration, distribution and marketing of the new digestive health product in 11 markets – Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Hungary, Latvia, Lithuania, Northern Macedonia, Serbia and Slovenia.

We value long-term partnerships and are very pleased to work with Salix. I am confident that the commercialization of the new product – due to its unique and innovative formulation – will strengthen our position in the digestive health segment throughout the CEE region, 

said Martina Perharič, Medis CEO.

We are very proud about this agreement and partnership with Medis, an important company recognized at international level,

said Linda Masello, Salix CEO, emphasizing that

the partnership with Medis is the result of our research and innovation capability and part of our long-term strategy to be a reference partner for international companies.

About Salix 

Salix, located in Monte di Malo (Vicenza), Italy, is active since 1999 and it is focused on the research, development and production of medical devices, food supplements, food supplements for special medical purposes. The production site, recently enlarged and renewed with new technologies and production lines, makes Salix at forefront for the production of solid and liquid dosage forms according to the highest international standards.

About Medis

With more than 30 years of experience, Medis is a recognized as a commercialization partner of choice for global pharmaceutical and biotechnology companies in the CEE region. By leveraging its marketing know-how, scientific expertise and product knowledge, Medis strives to make advanced medical treatments accessible to every patient in this region. Medis maintains its own subsidiaries in 17 countries and offers a full range of services to its partners. 

Related news